Two-stage model-free tests of synergy in drug combinations

Journal of Biopharmaceutical Statistics

Volumn 22, Issue 1, 2012, Pages 54-71

  Kelly, Colleen ^a   Feng, Ping ^b   Kawashima, Toana ^c   Wilmes, Anja ^d   Miller, John ^d  

^a Kelly Statistical Consulting   (United States)

^b SICHUAN UNIVERSITY   (China)

^c Fred Hutchinson Cancer Research Center   (United States)

^d VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

Author keywords

Additivity; Dose response curve; Drug interactions; Non monotonic tests

Indexed keywords

ANTINEOPLASTIC AGENT; EPOTHILONE A; PELORUSIDE A; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; DOSE RESPONSE; DRUG COMBINATION; DRUG POTENCY; DRUG POTENTIATION; MODEL FREE TEST; MONTE CARLO METHOD; NULL HYPOTHESIS; PRIORITY JOURNAL; PROBABILITY; STATISTICAL ANALYSIS; STATISTICAL MODEL; THEORETICAL STUDY;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG INTERACTIONS; DRUG SYNERGISM; HUMANS; MODELS, THEORETICAL; PHARMACEUTICAL PREPARATIONS;

EID: 84863012577     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543406.2010.504314     Document Type: Article

References (35)

1. Berenbaum, M. C. (1985). The expected effect of a combination of agents: The general solution. Journal of Theoretical Biology 114: 413-431. (Pubitemid 16237898)
2. Berenbaum, M. C. (1989). What is synergy? Pharmacology Reviews 41: 93-141. (Pubitemid 20019599)
3. Bliss, C. I. (1939). The toxicity of poisons applied jointly. Annals of Applied Biology 26: 585-615.
4. Casella, G., Berger, R. L. (2002). Statistical Inference., 2nd ed. Pacific Grove, PA: Duxbury Thomson Learning.
5. Feng, P., Kelly, C. (2004). An extension of the Model free test to test synergy in multiple drug combinations. Biometrical Journal 3: 293-304. (Pubitemid 41449108)
6. Gaitanos, T. N., Buey, R. M., Daz, J. F., Northcote, P. T., Teesdale-Spittle, P., Andreu, J. M., Miller, J. H. (2004). Deluroside A does not bind to the taxoid site on -tubulin and retains its activity in multidrug resistant cell lines. Cancer Research 64: 5063-5067. (Pubitemid 39006519)
7. Gazitt, Y., Rothenberg, M. L., Hilsenbeck, S. G., Fey, V., Thomas, C., Montgomery, W. (1998). Bcl-2 overexpression is associated with resistance to paclitaxel, but not gemcitabine, in multiple myeloma cells. International Journal of Oncology 13: 839-848. (Pubitemid 28435362)
8. Gennings, C., Carter, W. H., Jr. (1995). Utilizing concentration-response data from individual components to detect statistically significant departures from addivitvity in chemical mixtures. Biometrics 51: 1264-1277. (Pubitemid 26030172)
9. Goldoni, M., Johansson, C. (2007). A mathematical approach to study combined effects of toxicants in vitro: Evaluation of the Bliss independence criterion and the Loewe additivity model. Toxicology In Vitro 21: 759-769. (Pubitemid 46603249)
10. Greco, W. R., Bravo, G., Parsons, J. C. (1995). The search for synergy: A critical review from a response surface perspective. Pharmacological Reviews 47: 331-383.
11. Herynk, M. H., Beyer, A. R., et al. (2006). Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor-positive human breast cancer cells. Molecular Cancer Therapeutics 5: 3023-3031. (Pubitemid 46092043)
12. Hood, K. A., Bckstrm, B. T., West, L. M., Northcote, P. T., Berridge, M. V., Miller, J. H. (2001). The novel cytotoxic sponge metabolite peloruside A, structurally similar to bryostatin-1, has unique bioactivity independent of protein kinase C. Anti-Cancer Drug Design 16: 155-166. (Pubitemid 34269750)
13. Hood, K. A., West, L. M., Rouwé, B., Northcote, P. T., Berridge, M. V., Wakefield, S. J., Miller, J. H. (2002). Peloruside A, a novel anti-mitotic agent with paclitaxel-like microtubule-stabilizing activity. Cancer Research 62: 3356-3360. (Pubitemid 34651377)
14. Hung, H. M. J. (1993). Two-stage tests for studying monotherapy and combination therapy in two-by-two factorial trials. Statistics in Medicine 12: 645-660. (Pubitemid 23131492)
15. Kawashima, T. (2003). Analysis of Drug Combination: Comparing the Marginal Dose-Response Curve Method and the Model-Free Test Method. Master's degree thesis, San Diego State University, San Diego CA.
16. Kelly, C., Rice, J. (1990). Monotone smoothing with application to dose-response curves and the assessment of synergism. Biometrics 46: 1071-1085.
17. Laska, E. M., Meisner, M. J. (1989). Testing whether an identified treatment is best. Biometrics 45: 1139-1151. (Pubitemid 20085456)
18. Laska, E. M., Meisner, M., Seigel, C. (1994). Simple designs and model-free tests for synergy. Biometrics 50: 834-841. (Pubitemid 24320830)
19. Lee, J. J., Kong, M., Ayers, G. D., Lotan, R. (2007). Interaction index and different methods for determining drug interaction in combination therapy. Journal of Biopharmaceutical Statistics 17: 461-480. (Pubitemid 46699662)
20. Li, N., Sood, S., et al. (2005). Overexpression of 5-lipoxygenase and cyclooxygenase 2 in hamster and human oral cancer and chemopreventive effects of zileuton and celecoxib. Clinical Cancer Research 11: 2089-2096. (Pubitemid 40471876)
21. Loewe, S., Muischnek, H. (1926). ber kombinations-wirkungen. 1. Mitteilung: hilfsmittle der fragestellung. Archives of Experimental Pathology and Pharmacology 114: 313-326.
22. Lu, G., Xiao, H., et al. (2008). Synergistic inhibition of lung tumorigenesis by a combination of green tea polyphenols and atorvastatin. Clinical Cancer Research 14: 4981-4988.
23. McDougal, A., Wormke, M., Calvin, J., Sate, S. (2001). Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator. Cancer Research 61: 3902-3907. (Pubitemid 32720948)
24. Miller, J. H., Rouwé, B., Gaitanos, T. N., Hood, K. A., Crume, K. P., Bckstrm, B. T., La Flamme, A. C., Berridge, M. V., Northcote, P. T. (2004). Peloruside A enhances apoptosis in H-ras-transformed cells and is cytotoxic to proliferating T cells. Apoptosis 9: 785-796. (Pubitemid 40941207)
25. Patel, H. I. (1991). Comparison of treatments in a combination therapy trial. Journal of Biopharmaceutical Statistics 1: 171-183.
26. Plummer, J. L., Gourlay, G. K. (1992). Letters to the editor: Reply to the letter of Dr. Gebhart. Pain 51: 387-388.
27. Plummer, J. L., Cmielewski, P. L., Gourlay, G. K., Owen, H., Cousins, M. J. (1992). Antinociceptive and motor effects of intrathecal morphine combined with intrathecal clonidine noradrenaline, carbachol or midasolam. Pain 49: 145-152.
28. Sarkar, S. K., Snapinn, S., Wang, W. (1995). On improving the min test for the analysis of combination drug trials. Journal of Statistical Computing and Simulation 51: 197-213.
29. Sethna, N. F., Liu, M., Gracely, R., Bennett, G. J., Max, M. B. (1998). Analgesic and cognitive effects of intravenous ketamine-alfentanil combinations versus either drug alone after intradermal capsaicin in normal subjects. Anesthesia Analgesia 86: 1250-1256. (Pubitemid 28249246)
30. Tallarida, R. J. (2000). Drug Synergism and Dose-Effect Data Analysis. New York: Chapman and Hall.
31. Weitman, S., Barrera, H., Moore, R., Gonzalez, C., Marty, J., Hilsenbeck, S., MacDonald, J. R., Waters, S. J., Hoff, D. V. (2000). MGI 114: Augmentation of antitumor activity when combined with topotecan. Journal of Pediatric Hematology/Oncology 22: 306-314. (Pubitemid 32290170)
32. West, L. M., Northcote, P. T., Battershill, C. N. (2000). Peloruside A: A potent cytotoxic macrolide isolated from the New Zealand marine sponge Mycale sp. Journal of Organic Chemistry 65: 445-449. (Pubitemid 30061125)
33. Wilmes, A., Bargh, K., Kelly, C., Northcote, P., Miller, J. (2007). Peloruside A synergizes with other microtubule stabilizing agents in cultured cancer cell lines. Molecular Pharmaceutics 4: 269-280. (Pubitemid 46640603)
34. 3, and sodium butyrate on differentiation in HL-60 cells. Oncology Research 12: 419-427. (Pubitemid 33781094)
35. Zheng, X., Chang, R. L., et al. (2006). Effects of 12- O -tetradecanoylphorbol-13-acetate (TPA) in combination with paclitaxel (Taxol) on prostate cancer LNCaP cells cultured in vitro or grown as xenograft tumors in immunodeficient mice. Clinical Cancer Research 12: 3444-3451.